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Background/introduction
Over the past decade, numerous small- and large-mole-
cule products have been developed for treatment of
neurodegenerative diseases with mixed success. When
administered systemically in vivo, the blood-brain bar-
rier (BBB) inhibits their delivery to the regions affected
by those diseases. A successful drug delivery system
requires transient, localized, and noninvasive targeting
of a specific tissue region as provided by Focused Ultra-
sound (FUS). Neurturin (NTN) is a neurotrophic factor
that has demonstrated to have neuroprotective and
regenerative effects on dopaminergic neurons in vivo
using invasive drug delivery methods. Utilizing recombi-
nant adeno-associated virus (rAAV), therapeutic genes
can be delivered to the brain for long-lasting treatments.
In this study, we investigate the neuroprotective and
neuroregenerative effects of non-invasively delivered
rAAV-GDNF vectors and NTN in a PD mouse model,
respectively.
Methods
FUS at 1.5 MHz with in-house polydisperse microbubbles
was performed. In the NTN study, NTN bioavailability
and downstream signaling were detected and quantified
through immunostaining for NTN, phosphorylated RET,
ERK1/2 and CREB. To test for neuroprotection and neu-
roregeneration, the 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine (MPTP) mouse model was used with FUS before
and after MPTP administration, respectively. In the rAAV
study, the expression of GDNF after 4 weeks due to AAV
transduction was assessed in MPTP mice using FUS-
mediated AAV delivery prior to MPTP administration (for
neuroprotection only).
Results and conclusions
In the neurotrophic study, within the first hour of NTN
administration, triggering of the signaling cascade was
detected downstream to the neuronal nuclei. In the ade-
noviral study, the ratio of ipsilateral (FUS treated for
FUS only and AAV+FUS groups) to the contralateral
side showed significantly higher live neurons ratio from
the AAV+FUS group (ANOVA, p=0.03) when compared
to the control, AAV only and FUS only groups. These
findings thus indicate the potential of the FUS method
to mediate transport of proteins and mediate gene deliv-
ery through the blood-brain barrier for reversibility of
the PD phenotype.
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